SynDermix announces the successful kick-off meeting of the project SDX-3103, a proprietary medical device for the treatment and prevention of ...
Read MoreThe Board of Directors announce a successful increase of share capital: A total of CHF 5 394 135.96 in loans ...
Read MoreSynDermix announces the election of a new Chairman and Board of Directors at the Annual General Meeting of 2018. ...
Read More